MARC Predoctoral Fellowship Program

MARC 博士前奖学金计划

• 批准号: 7158857
• 负责人: Rebecca Baerga
• 金额: $ 2.92万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-01 至 2010-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7158857
• 关键词: RNA interference; autophagy; biological models; cytogenetics; functional /structural genomics; gene induction /repression; genetically modified animals; laboratory mouse; minority health professional; mutant; neoplasm /cancer genetics; neoplasm /cancer therapy; neoplastic growth; phosphorylation; posttranslational modifications; predoctoral investigator; protein kinase; protein localization; protein protein interaction; tissue /cell culture; tumor suppressor proteins

DESCRIPTION (provided by applicant): The process of autophagy is a complex catabolic program for lysosomal degradation of proteins and other subcellular constituents. It is important for normal growth control and is defective in a number of cancers. Beclin 1 gene is the first mammalian gene identified involved in autophagy. Mono-allelic deletions of Beclin 1 gene are identified in 40 -75% of human sporadic breast, ovarian and prostate cancers. Homozygous Beclin 1 knockout mice are embryonic lethal, while the heterozygous Beclin 1 knockout mice develop various tumors. This mouse genetic result provides compelling evidence that autophagy plays an important role in preventing tumorigenesis. However, exactly why the Beclin 1 gene and autophagy are critical for tumor suppression remains unknown. The re-activation of autophagy may be an efficient cancer therapeutic strategy. Preliminary data indicates that exogenous expression of the Beclin 1 mutant which mimics constitutive phosphorylation in MCF7 cells results in the activation of autophagy. This tool will be used to construct cellular and animal models to characterize the consequence of re-activating autophagy.

描述（由申请人提供）：自噬过程是一个复杂的分解代谢程序，用于蛋白质和其他亚细胞成分的溶酶体降解。 这对于正常生长控制很重要，并且在许多癌症中有缺陷。 Beclin 1基因是鉴定出自噬的第一个哺乳动物基因。 在40 -75％的人类零星乳房，卵巢癌和前列腺癌中鉴定出Beclin 1基因的单相关缺失。 纯合子Beclin 1基因敲除小鼠是胚胎致死的，而杂合的Beclin 1基因敲除小鼠会出现各种肿瘤。 该小鼠遗传结果提供了令人信服的证据，表明自噬在预防肿瘤发生中起着重要作用。 然而，确切地说是为什么Beclin 1基因和自噬对于抑制肿瘤至关重要。 自噬的重新激活可能是一种有效的癌症治疗策略。 初步数据表明，Beclin 1突变体的外源表达，该突变体模仿MCF7细胞中的本构磷酸化导致自噬的激活。 该工具将用于构建细胞和动物模型，以表征重新激活自噬的结果。